<HTML>
<HEAD>
   <TITLE>form8kholdings.htm - Generated by SEC Publisher for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">

<a name="page_1"></a>
<div style='border:none;border-top:double windowtext 1.5pt;padding:2.0pt 0in 0in 0in;'>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:14.0pt;'>UNITED STATES <br>
SECURITIES AND EXCHANGE COMMISSION<br>
WASHINGTON, DC 20549</font></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:18.0pt;'>FORM 8-K<br>
</font></b><b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>CURRENT REPORT</font></b></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</font></b></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>Date of report (Date of earliest event reported):&#160; February 24, 2010</font></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:18.0pt;'>Innophos Holdings, Inc.<br>
</font></b><font face="Times New Roman" lang=EN-US style='font-size:8.0pt;'>(Exact name of Registrant as specified in its their Charter)</font></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p align=center style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
</div>
<div align=center>
<table cellpadding=0 cellspacing=0 border=0 style='border-collapse:collapse;width:514.799988pt;'>
<tr>
     <td valign=top width=35% style='padding:0in 6.0pt 0in 6.0pt;'>
<p style='margin:0in;margin-bottom:.0001pt;text-align:center;'>
<a name="_Hlk216085884"></a><b><font face="Times New Roman" style='font-size:10.0pt;'>Delaware</font></b><b><font face="Times New Roman" style='font-size:8.0pt;'><br>
</font></b><font face="Times New Roman" style='font-size:8.0pt;'>(States or other jurisdictions of incorporation)</font></p>
</td>
     <td valign=top width=31% style='padding:0in 6.0pt 0in 6.0pt;'>
<p style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font face="Times New Roman" style='font-size:10.0pt;'>001-33124</font></b><b><font face="Times New Roman" style='font-size:8.0pt;'><br>
</font></b><font face="Times New Roman" style='font-size:8.0pt;'>(Commission File Numbers)</font></p>
</td>
     <td valign=top width=34% style='padding:0in 6.0pt 0in 6.0pt;'>
<p style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font face="Times New Roman" style='font-size:10.0pt;'>20-1380758</font></b><b><font face="Times New Roman" style='font-size:8.0pt;'><br>
</font></b><font face="Times New Roman" style='font-size:8.0pt;'>(IRS Employer Identification Nos.)</font></p>
</td> </tr> </table> </div>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>259 Prospect Plains Road</font></b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'><br>
</font><b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>Cranbury, New Jersey 08512</font></b><font face="Times New Roman" lang=EN-US style='font-size:8.0pt;'><br>
(Address of Principal Executive Office, including&#160; Zip Code)</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>(609) 495-2495</font></b><font face="Times New Roman" lang=EN-US style='font-size:8.0pt;'><br>
(Registrant&#8217;s Telephone Number, Including Area Code)</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:10.0pt;margin-left:0in;margin-right:0in;margin-top:30.0pt;text-align:center;'><b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>Not Applicable</font></b><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'><br>
</font><font face="Times New Roman" lang=EN-US style='font-size:8.0pt;'>(Former name or former address, if changed since last report)</font></p>
<div style='border:none;border-bottom:double windowtext 1.5pt;padding:0in 0in 1.0pt 0in;'>
<p style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></p>
<p style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>[&#160; ]&#160; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p>
<p style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>[&#160; ]&#160; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
<p style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>[&#160; ]&#160; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
<p style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>[&#160; ]&#160; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
<p style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p style='border:none;margin:0in;margin-bottom:.0001pt;padding:0in;'><font face="Times New Roman" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
</div>
<HR noshade align="center" width="100%" size=2>
<DIV STYLE="page-break-before: always"></div>
<A name="page_2"></A>
<P style="MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">Item 1.01 Entry into a Material Definitive Agreement</FONT></B></P>
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman"></FONT>&nbsp;</P>
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As the Registrant previously reported, on February 24, 2010, the Registrant&#146;s Mexican subsidiaries, or Innophos Mexico, and OCP, S.A., or OCP, their phosphate rock supplier, settled and terminated arbitration proceedings between them pending since 2008.&nbsp; On that date, those parties also entered into an amendment to their existing 1992 supply agreement, or the 1992 Agreement, previously filed by the Registrant. </FONT></P>
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman"></FONT>&nbsp;</P>
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The major features in the amendment, identified as Addendum No. 13 to the 1992 Agreement, are the following terms and conditions:</FONT></P>
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman"></FONT>&nbsp;</P>
<P style="TEXT-INDENT: -0.4in; MARGIN: 0in 0in 0pt 0.5in"><FONT style="FONT-SIZE: 8pt" lang=EN-US face=Wingdings>&#167;</FONT><FONT style="FONT-SIZE: 7pt" lang=EN-US face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">2008 and 2009 final prices for phosphate rock are agreed to be the interim prices already paid by Innophos Mexico;</FONT></P>
<P style="TEXT-INDENT: -0.4in; MARGIN: 0in 0in 0pt 0.5in"><FONT style="FONT-SIZE: 8pt" lang=EN-US face=Wingdings>&#167;</FONT><FONT style="FONT-SIZE: 7pt" lang=EN-US face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">2010 final prices and estimated volumes of phosphate rock (until the end of the 1992 Agreement scheduled for September 10, 2010) are set for Innophos Mexico&#146;s Coatzacoalcos, Veracruz, Mexico plant, together with mutual minimum volume commitments for each of the two types of phosphate rock to be supplied;</FONT></P>
<P style="TEXT-INDENT: -0.4in; MARGIN: 0in 0in 0pt 0.5in"><FONT style="FONT-SIZE: 8pt" lang=EN-US face=Wingdings>&#167;</FONT><FONT style="FONT-SIZE: 7pt" lang=EN-US face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">Innophos Mexico is afforded an option to extend the 1992 Agreement to December 31, 2010, if the option is exercised by July 31, 2010, without additional volume commitments;</FONT></P>
<P style="TEXT-INDENT: -0.4in; MARGIN: 0in 0in 0pt 0.5in"><FONT style="FONT-SIZE: 8pt" lang=EN-US face=Wingdings>&#167;</FONT><FONT style="FONT-SIZE: 7pt" lang=EN-US face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">Exclusivity of OCP as a supplier would terminate as of September 10, 2010; </FONT></P>
<P style="TEXT-INDENT: -0.4in; MARGIN: 0in 0in 0pt 0.5in"><FONT style="FONT-SIZE: 8pt" lang=EN-US face=Wingdings>&#167;</FONT><FONT style="FONT-SIZE: 7pt" lang=EN-US face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">Innophos Mexico receives an option before September 10, 2010 to purchase limited quantities of third party phosphate rock for testing purposes; and&nbsp; </FONT></P>
<P style="TEXT-INDENT: -0.4in; MARGIN: 0in 0in 0pt 0.5in"><FONT style="FONT-SIZE: 8pt" lang=EN-US face=Wingdings>&#167;</FONT><FONT style="FONT-SIZE: 7pt" lang=EN-US face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">The 1992 Agreement is revised in a number of other respects, including as to its </FONT><I><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">force majeure</FONT></I><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman"> provisions, limitations of damages and liquidated damages.&nbsp; </FONT></P>
<P style="MARGIN: 0in 0in 0pt 0.1in"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman"></FONT>&nbsp;</P>
<P style="MARGIN: 0in 0in 0pt 0.1in"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A redacted version of Addendum No.13 has been filed as Exhibit 99.1 to this Current Report on Form 8-K. The full version of that document has been made the subject of an application for confidential treatment with Securities and Exchange Commission.</FONT></P>
<P style="MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman"></FONT></B>&nbsp;</P>
<P style="MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">Item 9.01 Financial Statements and Exhibits.</FONT></B></P>
<P style="MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman"></FONT></B>&nbsp;</P>
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">The following exhibits are filed with this report:</FONT></P>
<P style="MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 11pt" lang=EN-US face="Times New Roman"></FONT></B>&nbsp;</P>
<DIV align=left>
<TABLE style="WIDTH: 100%" border=0 cellSpacing=0 cellPadding=0 width="100%">
<TR>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=bottom width="15%">
<P style="MARGIN: 0in 0in 0pt"><B><U><FONT style="FONT-SIZE: 10pt" face="Times New Roman">(d) Exhibit No.</FONT></U></B><U><FONT style="FONT-SIZE: 10pt" face="Times New Roman">&nbsp; </FONT></U></P>
</TD>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=bottom width="85%">
<P style="MARGIN: 0in 0in 0pt"><B><U><FONT style="FONT-SIZE: 10pt" face="Times New Roman">Description</FONT></U></B><U><FONT style="FONT-SIZE: 10pt" face="Times New Roman">&nbsp; </FONT></U></P>
</TD></TR>
<TR>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=bottom width="15%">
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="Times New Roman"></FONT>&nbsp;</P>
</TD>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=bottom width="85%">
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="Times New Roman"></FONT>&nbsp;</P>
</TD></TR>
<TR>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=bottom width="15%">
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 99.1&nbsp; </FONT></P>
</TD>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" vAlign=bottom width="85%">
<P style="MARGIN: 0in 0in 0pt"><FONT style="TEXT-TRANSFORM: uppercase; FONT-SIZE: 10pt" face="Times New Roman">Addendum No. 13 between OCP, s.A. &nbsp;and Innophos Mexicana, S.A de CV. Dated February 24, 2010</FONT><FONT style="FONT-SIZE: 10pt" face=serif>*</FONT></P>
</TD></TR></TABLE></DIV>
<P style="MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 11pt" lang=EN-US face="Times New Roman"></FONT></B>&nbsp;</P>
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face=serif>* Filed in redacted form pending request for confidential treatment being submitted to the Securities and Exchange Commission under&nbsp; Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</FONT></P>
<P style="MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 11pt" lang=EN-US face="Times New Roman"></FONT></B>&nbsp;</P>
<DIV align=left>
<TABLE style="WIDTH: 521.349pt; BORDER-COLLAPSE: collapse" border=0 cellSpacing=0 cellPadding=0 width=666>
<TR>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0in" vAlign=top width="50%">
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" face="Times New Roman"></FONT>&nbsp;</P>
</TD>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0in" vAlign=top width="50%">
<P style="MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" face="Times New Roman">SIGNATURES<BR>
<BR>
</FONT></B></P>
</TD></TR></TABLE></DIV>
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">According to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</FONT></P>
<DIV align=left>
<TABLE style="WIDTH: 518.399pt; BORDER-COLLAPSE: collapse" border=0 cellSpacing=0 cellPadding=0>
<TR>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0in" vAlign=top width="50%">
<P style="MARGIN: 0in 0.6pt 0pt 0in"><FONT style="FONT-SIZE: 12pt" face="Times New Roman"></FONT>&nbsp;</P>
</TD>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0in" vAlign=top width="50%">
<P style="MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" face="Times New Roman">INNOPHOS HOLDINGS, INC.</FONT></B></P>
</TD></TR>
<TR>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0in" vAlign=top width="50%">
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" face="Times New Roman"></FONT>&nbsp;</P>
</TD>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0in" vAlign=top width="50%">
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="Times New Roman"></FONT>&nbsp;</P>
</TD></TR>
<TR>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0in" vAlign=top width="50%">
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" face="Times New Roman"></FONT>&nbsp;</P>
</TD>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0in" vAlign=top width="50%">
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="Times New Roman">By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U><FONT style="FONT-SIZE: 10pt" face="Times New Roman">/s/ William Farran</FONT></U></P>
</TD></TR>
<TR>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0in" vAlign=top width="50%">
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 12pt" face="Times New Roman"></FONT>&nbsp;</P>
</TD>
     <TD style="PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0in" vAlign=top width="50%">
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" face="Times New Roman">Name: &nbsp;&nbsp;&nbsp; William Farran<BR>
Title: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vice President and General Counsel</FONT></P>
</TD></TR></TABLE></DIV>
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman">Dated: February 26, 2010.</FONT></P>
<HR align=center SIZE=2 width="100%" noShade>
<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
</BODY>

</HTML>
[{"type": "8-K", "sequence": "1", "filename": "form8kholdings.htm", "description": "8K", "secsgml_size_bytes": 21386}]
{"company-data": {"conformed-name": "Innophos Holdings, Inc.", "cik": "0001364099", "assigned-sic": "5160", "irs-number": "201380758", "fiscal-year-end": "1207"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-33124", "film-number": "10640138"}, "business-address": {"street1": "259 PROSPECT PLAINS ROAD", "city": "CRANBURY", "state": "NJ", "zip": "08512", "phone": "(609) 495 2495"}, "mail-address": {"street1": "259 PROSPECT PLAINS ROAD", "city": "CRANBURY", "state": "NJ", "zip": "08512"}}
form8kholdings.htm - Generated by SEC Publisher for SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):  February 24, 2010
Innophos Holdings, Inc.
(Exact name of Registrant as specified in its their Charter)
Delaware
(States or other jurisdictions of incorporation)
001-33124
(Commission File Numbers)
20-1380758
(IRS Employer Identification Nos.)
259 Prospect Plains Road
Cranbury, New Jersey 08512
(Address of Principal Executive Office, including  Zip Code)
(609) 495-2495
(Registrant's Telephone Number, Including Area Code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement
As the Registrant previously reported, on February 24, 2010, the Registrant's Mexican subsidiaries, or Innophos Mexico, and OCP, S.A., or OCP, their phosphate rock supplier, settled and terminated arbitration proceedings between them pending since 2008.  On that date, those parties also entered into an amendment to their existing 1992 supply agreement, or the 1992 Agreement, previously filed by the Registrant.
The major features in the amendment, identified as Addendum No. 13 to the 1992 Agreement, are the following terms and conditions:
§
2008 and 2009 final prices for phosphate rock are agreed to be the interim prices already paid by Innophos Mexico;
§
2010 final prices and estimated volumes of phosphate rock (until the end of the 1992 Agreement scheduled for September 10, 2010) are set for Innophos Mexico's Coatzacoalcos, Veracruz, Mexico plant, together with mutual minimum volume commitments for each of the two types of phosphate rock to be supplied;
§
Innophos Mexico is afforded an option to extend the 1992 Agreement to December 31, 2010, if the option is exercised by July 31, 2010, without additional volume commitments;
§
Exclusivity of OCP as a supplier would terminate as of September 10, 2010;
§
Innophos Mexico receives an option before September 10, 2010 to purchase limited quantities of third party phosphate rock for testing purposes; and
§
The 1992 Agreement is revised in a number of other respects, including as to its
force majeure
provisions, limitations of damages and liquidated damages.
A redacted version of Addendum No.13 has been filed as Exhibit 99.1 to this Current Report on Form 8-K. The full version of that document has been made the subject of an application for confidential treatment with Securities and Exchange Commission.
Item 9.01 Financial Statements and Exhibits.
The following exhibits are filed with this report:
(d) Exhibit No.
Description
99.1
Addendum No. 13 between OCP, s.A.  and Innophos Mexicana, S.A de CV. Dated February 24, 2010
*
* Filed in redacted form pending request for confidential treatment being submitted to the Securities and Exchange Commission under  Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
SIGNATURES
According to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
INNOPHOS HOLDINGS, INC.
By:
/s/ William Farran
Name:     William Farran
Title:       Vice President and General Counsel
Dated: February 26, 2010.